Z-0110-2024Class II
BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023
Becton Dickinson & Co / initiated 2023-09-12 / Open, Classified / root cause: labeling and UDI
Becton Dickinson & Co. began a recall of BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023 on . FDA classified it as Class II and gives the reason as "Certain vials of the BD BACTEC" Plus Aerobic/F Culture Vials have a labeling issue where duplicate barcode sequence numbers have been identified on more than one vial". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-0110-2024
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Becton Dickinson & Co
- Product
- BD BACTEC Plus Aerobic/F Culture Vials, Catalog Number 442023
- Product code
- MDB System, Blood Culturing
- Reason for recall
- Certain vials of the BD BACTEC" Plus Aerobic/F Culture Vials have a labeling issue where duplicate barcode sequence numbers have been identified on more than one vial.
- Root cause tag
- labeling and UDI
- FDA root cause
- Under Investigation by firm
- Action
- An URGENT: Medical Device Product Correction notification letter dated 9/12/23 was sent to customers. Please Take the Following Actions: 1. Immediately inspect your inventory for the specific catalog and lot numbers listed above to determine if the BD BACTEC" Plus Aerobic/F Culture Vials in your possession are impacted. 2. Ensure the contents of this Product Advisory are read and understood. 3. Share and post this recall letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness. 4. Users should verify that the accession number on the BD BACTEC" Instrument loading screen matches the vial's accession number while scanning and loading onto the instrument. If an error message or other system action occurs when loading vials into the BD BACTEC" Instrument that indicates a potential issue with duplicate sequence numbers, it is recommended to follow the instructions within the message and to view the table of System Alerts located in 7 Troubleshooting of the BD BACTEC" FX Instrument User s Manual before taking any further action in vial processing. The URL link to access the BD BACTEC" FX Instrument User s Manual is noted below. There are no additional follow-up activities recommended for patient samples processed. https://eifu.bd.com/en/search/search-results?term=441385&cats=9444_9445,9441_9443,9441_9442,1185_1206,1185 5. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification per FDA requirements. 6. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fisher s Lane, Rockville, MD 20852-9787 Distributors Please Ta
- Quantity in commerce
- 781,600 vials
- Distribution
- Worldwide - US Nationwide distribution.
- Product codes and lots
- UDI-DI: 038290HXRPGWNNMN; Lot Numbers: 3062843 3062846 3062849 3062847 3067489 3067488
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0110-2024 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
